NRx Pharmaceuticals, Inc. (NRXP)
NASDAQ: NRXP · Real-Time Price · USD
3.280
+0.070 (2.18%)
At close: May 15, 2026, 4:00 PM EDT
3.250
-0.030 (-0.93%)
After-hours: May 15, 2026, 7:58 PM EDT
NRx Pharmaceuticals Revenue
In the year 2025, NRx Pharmaceuticals had annual revenue of $1.23M. NRx Pharmaceuticals had revenue of $983.00K in the quarter ending December 31, 2025.
Revenue (ttm)
$1.23M
Revenue Growth
n/a
P/S Ratio
86.83
Revenue / Employee
$42,241
Employees
29
Market Cap
108.35M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.23M | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Q32 Bio | 53.74M |
| Verrica Pharmaceuticals | 37.16M |
| Rani Therapeutics Holdings | 1.63M |
| Cardiff Oncology | 593.00K |
| Inovio Pharmaceuticals | 65.34K |
NRXP News
- 1 day ago - NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report First Quarter 2026 Financial Results and Provide Corporate Update - GlobeNewsWire
- 2 days ago - NRx Pharmaceuticals initiated with a Buy at Lucid Capital - TheFly
- 8 days ago - NRx Pharmaceuticals gets FDA clearance to initiate NRX-101 trial - TheFly
- 8 days ago - NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Clearance to Proceed with Clinical Trial of NRX-101 in Combination with Robotic-enabled Transcranial Magnetic Stimulation in Patients with Depression and Suicidality - GlobeNewsWire
- 10 days ago - NRx Pharmaceuticals receives first commercial manufacturing order for ketamine - TheFly
- 10 days ago - NRx Pharmaceuticals (Nasdaq:NRXP) Announces Initiation of Commercial Manufacturing for Preservative Free Ketamine - GlobeNewsWire
- 23 days ago - NRx Pharmaceuticals gets FDA feedback on ketamine program - TheFly
- 23 days ago - NRx Pharmaceuticals Reports Positive FDA Office of Generic Drugs Feedback on Preservative-Free Ketamine Program - GlobeNewsWire